Recent Quotes

My Watchlist

Indicators

Scinai Immunotherapeutics Ltd ADR (NQ: SCNI )

3.360 -0.140 (-4.00%)

Streaming Delayed Price Updated: 3:59 PM EST, Nov 8, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	31,605
Open	3.510
Bid (Size)	3.360 (5)
Ask (Size)	3.450 (1)
Prev. Close	3.500
Today's Range	3.330 - 3.555
52wk Range	2.230 - 8.920
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

New Toolkit Launched to Boost Marburg Screening Readiness in the US

October 31, 2024

Via Investor Brand Network

BioMedNewsBreaks — Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Spotlight Innovative I&I Pipeline and CDMO Services at BIO-Europe 2024

October 31, 2024

Via Investor Brand Network

Performance

YTD	-44.89%	-44.89%
1 Month	-10.64%	-10.64%
3 Month	-8.20%	-8.20%
6 Month	-22.06%	-22.06%
1 Year	-51.30%	-51.30%

More News

Researchers Shine Spotlight on New Barriers to Vaccination

October 14, 2024

Via Investor Brand Network

Whooping Cough Prevalence Rises in US as Missed Shots During Pandemic Come Home to Roost

September 25, 2024

Via Investor Brand Network

BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Schedules Virtual Panel Discussion on Plaque Psoriasis, Its Promising Novel Solution

September 16, 2024

Via Investor Brand Network

BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) CEO Featured Guest on Latest Episode of BioMedWire Podcast

September 09, 2024

Via Investor Brand Network

New Approach Could Boost Effectiveness of Immunotherapies Against Colorectal Cancer

September 04, 2024

Via Investor Brand Network

BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), EIB Close on Loan Restructuring Agreement

August 21, 2024

Via Investor Brand Network

BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Enters Into $2M Investment Commitment Agreement with Its Largest Existing Shareholder

August 20, 2024

Via Investor Brand Network

SCNI Stock Earnings: Scinai Immunotherapeutics Reported Results for Q2 2024

August 15, 2024

Via InvestorPlace

BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports Q2 2024 Financial Results, Shares Business Update

August 15, 2024

Via Investor Brand Network

BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Signs Definitive Loan Restructuring Agreement with EIB Converting Debt into Equity

August 13, 2024

Via Investor Brand Network

Australia Launches Novel Immunotherapy Program to Help Babies with Peanut Allergies

August 09, 2024

Via Investor Brand Network

7 F-Rated Stocks for Your August 2024 Sell List

August 05, 2024

Via InvestorPlace

Study Highlights Heightened Risk of Diseases Spreading from Animals to Humans

July 26, 2024

Via Investor Brand Network

BioMedNewsBreaks — Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Receives PEI Feedback Regarding Development, Preclinical Trial of Anti-IL-17 NanoAb

July 23, 2024

Via Investor Brand Network

Crude Oil Moves Lower; Goldman Sachs Posts Upbeat Results

July 15, 2024

Via Benzinga

Why SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session

July 15, 2024

Via Benzinga

Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

July 17, 2024

Via Benzinga

PLUG Stock Alert: Plug Power Gets Approval for HyVia Acquisition

July 15, 2024

Via InvestorPlace

M Stock Plunges 13% as Macy’s Calls Off Take-Private Talks

July 15, 2024

Via InvestorPlace

Nasdaq Surges Over 1%; Lexeo Therapeutics Shares Plummet

July 15, 2024

Via Benzinga

Why Is Scinai Immunotherapeutics (SCNI) Stock Up 56% Today?

July 15, 2024

Via InvestorPlace

BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases Successful Preclinical Results In-Vivo Proof-of-Concept Psoriatic Human Skin Model Study

July 15, 2024

Via Investor Brand Network

Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Falls In July

July 15, 2024

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.